FindTrial
Sign In

Non-Alcoholic Fatty Liver Disease with Newly confirm Diabetes And Its connection With BMI, HBA1c And Standard Lipid Profile and Missed Opportunities for Earlier Diagnosis of Diabetes and NAFLD

Non-Alcoholic Fatty Liver Disease Among Newly Diagnosed T2DM And Its Correlation With BMI, HBA1c And Standard Lipid Profile and Missed Opportunities for Earlier Diagnosis of Type2 DM and NAFLD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/09/045835
Enrollment
384
Registered
2022-09-23
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

None listed

Sponsors

Dr Supriyo Mukherjee
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male and female subjects aged 18 years & above. 2. Newly Diagnosed T2DM patients or recently diagnosed T2DM patients within 6 months of study participation 3. Availability of complete socio-demographic and clinical data relevant to the purpose of the study 4. Subjects willing to provide informed written consent

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with T1DM 2. A record of any amount of liquor consumption 3. Female patients who were pregnant or breast feeding during the study time period 4. Non-pharmacologically treated diabetes or Past record of traditional medicine ingestion 5. A past record of acute hepatitis (Hep A, B, C, Amoebic liver disease) of any cause within 6 months to dismiss any information bias related to abnormal (Liver function test) LFT findings 6. Chronic Liver Disease or an ongoing history of Wilson disease, hemochromatosis, autoimmune hepatitis, and alpha 1- antitrypsin deficiency 7. Malignancy which might involve liver 8. Subjects with any other illness or health condition which in the opinion/medical judgement of the study investigator makes the subject ineligible to participate in the study.

Design outcomes

Primary

MeasureTime frame
The prevalence of Non-alcoholic fatty liver disease among newly diagnosed T2DM in North Bihar and its correlation with BMI, HBA1c and standard lipid profile within population of North BiharTimepoint: At baseline—

Secondary

MeasureTime frame
To determine if there are missed opportunities for earlier diagnosis and understand how Newly diagnosed persons with T2DM develop symptoms of diabetes and NAFLD and clinically presentTimepoint: At Baseline;To determine predictors of NAFLD in newly diagnosed T2DMTimepoint: At Baseline—

Countries

India

Contacts

Public ContactDr Supriyo Mukherjee

Research Centre for Diabetes Hypertension and Obesity (RCDHO)

drsupriyomukherjee@gmail.com9431245660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026